Early Recognition of Treatment‐Responsive Rapidly Progressive Dementia: The Modified <scp> STAM3 <sup>m</sup> P </scp> Score

ABSTRACT Early identification of patients with treatment‐responsive rapidly progressive dementia (RPD) is important as early treatment improves outcomes. The STAM 3 P score identifies treatment‐responsive RPD using “high risk” presenting features. We optimized performance by adding a time component (i.e., dementia within 3 months) and validated the modified “STAM3 m P score” in two independent cohorts ( n = 302). A STAM3 m P score ≥ 1 identified 96% of patients with treatment‐responsive RPD; ≥ 3 features were highly specific (98%). These data suggest that ≥ 1 STAM3 m P features effectively identifies treatment‐responsive RPD and may be used to prioritize investigations, whereas ≥ 3 STAM3 m P features are highly specific and may inform early treatment decisions.

Authors

Institutions

Publication Details

Journal
Annals of Clinical and Translational Neurology
Published
2026-05-27
DOI
https://doi.org/10.1002/acn3.70434
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early Recognition of Treatment‐Responsive Rapidly Progressive Dementia: The Modified STAM3 m P Score

E.G.P. Dopper, H. Seelaar, P.A.E. Sillevis Smitt, F A de Jong et al.
Annals of Clinical and Translational Neurology
Dementia and Cognitive Impairment Research
article

Early Recognition of Treatment‐Responsive Rapidly Progressive Dementia: The Modified STAM3 m P Score

E.G.P. Dopper, H. Seelaar, P.A.E. Sillevis Smitt, F A de Jong, M. J. Titulaer, S. Veenbergen, N. Satyadev, J. M. de Vries, J. Kerstens, A. E. M. Bastiaansen, J. Brenner, T. M. Bienfait, Y. S. Crijnen, G. S. Day, Y. D. Piura, T. Brand, R. W. van Steenhoven
article en

Abstract

ABSTRACT Early identification of patients with treatment‐responsive rapidly progressive dementia (RPD) is important as early treatment improves outcomes. The STAM 3 P score identifies treatment‐responsive RPD using “high risk” presenting features. We optimized performance by adding a time component (i.e., dementia within 3 months) and validated the modified “STAM3 m P score” in two independent cohorts ( n = 302). A STAM3 m P score ≥ 1 identified 96% of patients with treatment‐responsive RPD; ≥ 3 features were highly specific (98%). These data suggest that ≥ 1 STAM3 m P features effectively identifies treatment‐responsive RPD and may be used to prioritize investigations, whereas ≥ 3 STAM3 m P features are highly specific and may inform early treatment decisions.

Annals of Clinical and Translational Neurology
Jacksonville College (US), Erasmus MC (NL), Antwerp University Hospital (BE), Mayo Clinic in Florida (US)
Good health and well-being
Openalex Percentile: Top 6%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.